As of 2025-07-18, the EV/EBITDA ratio of ImmuPharma PLC (IMM.L) is -2.22. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. IMM.L's latest enterprise value is 10.51 mil GBP. IMM.L's TTM EBITDA according to its financial statements is -4.73 mil GBP. Dividing these 2 quantities gives us the above IMM.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2025-07-17 | -2.22 |
| 2025-07-16 | -2.02 |
| 2025-07-15 | -2.03 |
| 2025-07-14 | -2.20 |
| 2025-07-11 | -2.33 |
| 2025-07-10 | -2.34 |
| 2025-07-09 | -2.34 |
| 2025-07-08 | -2.32 |
| 2025-07-07 | -2.37 |
| 2025-07-04 | -2.36 |
| 2025-07-03 | -2.44 |
| 2025-07-02 | -2.37 |
| 2025-07-01 | -2.41 |
| 2025-06-30 | -2.50 |
| 2025-06-27 | -2.74 |
| 2025-06-26 | -2.75 |
| 2025-06-25 | -2.46 |
| 2025-06-24 | -2.43 |
| 2025-06-23 | -2.52 |
| 2025-06-20 | -2.60 |
| 2025-06-19 | -2.48 |
| 2025-06-18 | -2.63 |
| 2025-06-17 | -2.61 |
| 2025-06-16 | -2.63 |
| 2025-06-13 | -2.64 |
| 2025-06-12 | -2.86 |
| 2025-06-11 | -2.92 |
| 2025-06-10 | -2.68 |
| 2025-06-09 | -2.91 |
| 2025-06-06 | -2.91 |
| 2025-06-05 | -2.91 |
| 2025-06-04 | -2.86 |
| 2025-06-03 | -2.88 |
| 2025-06-02 | -2.89 |
| 2025-05-30 | -2.89 |
| 2025-05-29 | -2.83 |
| 2025-05-28 | -2.94 |
| 2025-05-27 | -2.99 |
| 2025-05-23 | -2.89 |
| 2025-05-22 | -2.95 |
| 2025-05-21 | -3.13 |
| 2025-05-20 | -3.11 |
| 2025-05-19 | -3.27 |
| 2025-05-16 | -3.67 |
| 2025-05-15 | -3.76 |
| 2025-05-14 | -3.78 |
| 2025-05-13 | -3.69 |
| 2025-05-12 | -3.77 |
| 2025-05-09 | -3.41 |
| 2025-05-08 | -3.25 |